Medication info
Evicseu Tablet 10mg (Memantine Hydrochloride)

Evicseu Tablet 10mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White, oblong film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201706905 · Approved 2017.08.31 · Insurance code 657806070

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily and should be taken at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. First week (days 1~7) Administer 5mg once daily for 7 days. Second week (days 8~14) Administer 10mg once daily for 7 days. Third week (days 15~21) Administer 15mg once daily for 7 days. From the fourth week onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg once daily after a minimum of 7 days of treatment, according to the standard dose escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily and should be taken at the same time each day. If necessary, this medicine may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. First week (days 1~7) Administer 5mg once daily for 7 days. Second week (days 8~14) Administer 10mg once daily for 7 days. Third week (days 15~21) Administer 15mg once daily for 7 days. From the fourth week onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly patients: Based on clinical data, the recommended dose for elderly patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg once daily after a minimum of 7 days of treatment, according to the standard dose escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients with hypersensitivity to its components or severe liver or kidney impairment. Caution should be exercised when administered to patients with epilepsy or those with a history of seizures, and in conjunction with certain neurological medications. This medication may affect the central nervous system, and side effects such as dizziness, headache, drowsiness, constipation, and high blood pressure may occur. Because there is a potential for drug interactions, caution is particularly needed when used with NMDA antagonists, antipsychotic medications, or anticoagulants. Women who are pregnant or nursing should consult a doctor before taking this medication, and use during breastfeeding is generally not recommended. The safety and efficacy of this medication have not been established for pediatric or adolescent patients under 18 years of age. In cases of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, and immediate medical attention is required. This medication may affect the patient's reaction speed, so caution is advised when driving or operating machinery. Store in a place inaccessible to children, and do not transfer to another container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug hypersensitivity reaction
  • confusion
  • hallucinations
  • psychotic reactions
Show 25 more
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • venous thrombosis
  • thromboembolism
  • shortness of breath
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • fatigue
  • nonspecific fatigue
  • weakness
  • diarrhea
  • anxiety
  • aggression
  • stupor
  • unconsciousness
  • restlessness
  • psychosis
  • visual hallucinations
  • convulsions
  • comatose state
  • double vision

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1°C and 30°C to preserve the medication's efficacy and safety.

Appearance and packaging

Appearance

White, oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.